Literature DB >> 26173246

Your Brain on Insulin: From Heresy to Dogma.

Ewan McNay1.   

Abstract

As recently as 1988, the idea that insulin might regulate cognitive and neural functions was, if not quite heretical, still seen as unlikely. As our ability to measure metabolic and molecular changes in the brain has improved, the hippocampus in particular has been revealed as a primary target for insulin. Today insulin is established as a key regulator of hippocampal fuel supply and a critical component of memory formation and storage within the hippocampus. Brain insulin signaling is a target for therapeutic intervention in patients with neuropsychological conditions such as Alzheimer's disease.
© The Author(s) 2013.

Entities:  

Keywords:  Alzheimer’s disease; diabetes; hippocampus; insulin; memory

Year:  2014        PMID: 26173246      PMCID: PMC5674786          DOI: 10.1177/1745691613514058

Source DB:  PubMed          Journal:  Perspect Psychol Sci        ISSN: 1745-6916


  18 in total

1.  Intranasal insulin improves memory in humans.

Authors:  Christian Benedict; Manfred Hallschmid; Astrid Hatke; Bernd Schultes; Horst L Fehm; Jan Born; Werner Kern
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

2.  Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task.

Authors:  E C McNay; T M Fries; P E Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

4.  Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats.

Authors:  W Zhao; H Chen; H Xu; E Moore; N Meiri; M J Quon; D L Alkon
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

Authors:  G Stennis Watson; Brenna A Cholerton; Mark A Reger; Laura D Baker; Stephen R Plymate; Sanjay Asthana; Mark A Fishel; J Jacob Kulstad; Pattie S Green; David G Cook; Steven E Kahn; Michelle L Keeling; Suzanne Craft
Journal:  Am J Geriatr Psychiatry       Date:  2005-11       Impact factor: 4.105

Review 6.  Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.

Authors:  Ewan C McNay; Andrew K Recknagel
Journal:  Neurobiol Learn Mem       Date:  2011-08-30       Impact factor: 2.877

7.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Authors:  Eric Steen; Benjamin M Terry; Enrique J Rivera; Jennifer L Cannon; Thomas R Neely; Rose Tavares; X Julia Xu; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2005-02       Impact factor: 4.472

Review 8.  Insulin: its relationship to the central nervous system and to the control of food intake and body weight.

Authors:  S C Woods; D Porte; E Bobbioni; E Ionescu; J F Sauter; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Am J Clin Nutr       Date:  1985-11       Impact factor: 7.045

9.  Glucose modulation of memory storage processing.

Authors:  P E Gold
Journal:  Behav Neural Biol       Date:  1986-05

Review 10.  Cerebral function in diabetes mellitus.

Authors:  G J Biessels; A C Kappelle; B Bravenboer; D W Erkelens; W H Gispen
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

View more
  1 in total

Review 1.  Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

Authors:  Corey J Frank; Ewan C McNay
Journal:  J Neuroendocrinol       Date:  2021-12-13       Impact factor: 3.627

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.